Mathematically modelling the spread of hepatitis C in injecting drug users

Mathematical Medicine and Biology

Volumn 29, Issue 3, 2012, Pages 205-230

  Corson, S ^a   Greenhalgh, D ^a   Hutchinson, S ^a,b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

Author keywords

HCV elimination; Hepatitis C; IDUs; Injecting drug users; Mathematical modelling

Indexed keywords

EPIDEMIOLOGY;

HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS ELIMINATION; IDU; INFECTIOUS DISEASE; INJECTING DRUG USER; MATHEMATICAL MODELING; POTENTIAL IMPACTS; PROPERTY; VIRUS ELIMINATION;

VIRUSES;

HEPATITIS C VIRUS;

EID: 84866430206     PISSN: 14778599     EISSN: 14778602     Source Type: Journal    
DOI: 10.1093/imammb/dqr011     Document Type: Article

References (37)

1. Advisory Council On The Misuse Of Drugs (2009) The primary prevention of hepatitis C among injecting drug users. Available at http://drugs.homeoffice.gov.uk/publication-search/acmd/acmdhepcreport22835.pdf
2. Aitken, C. K., Lewis, J., Tracy, S. L., Spelman, T., Bharadwaj, M., Bowden, D. S., Drummer, H. & Hellard, M. E. (2008) High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology, 48, 1749-1752.
3. Bialek, S. & Terrault, N. (2006) The changing epidemiology and natural history of hepatitis C virus infection. Clin. Liver Dis., 10, 697-715.
4. Caulkins, J. P. & Kaplan, E. H. (1991) AIDS impact on the number of intravenous drug users. Interfaces, 21, 50-63.
5. Chow, S. N. & Hale, J. K. (1982) Methods of Bifurcation Theory. New York: Springer.
6. Farci, P., Alter, H. J., Govindarajan, S., Wong, D. C., Engle, R., Lesniewski, R. R., Mushahwar, I. K., Desai, S. M., Miller, R. H., Ogata, N. & Purcell, R. H. (1992) Lack of protective immunity against reinfection with hepatitis C virus. Science, 258, 135-140.
7. Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E. & Vlahov, D. (1998) Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 18, S11-S19.
8. Greenhalgh, D. (1997) Bounds on endemic disease levels, risks and basic reproductive numbers in heterogenous models for HIV/AIDS amongst injecting drug users. J. Biol. Syst., 5, 151-180.
9. Greenhalgh, D. & Hay, G. (1997) Mathematical modelling of the spread of HIV/AIDS amongst injecting drug users. IMA J. Math. Med. Biol., 14, 11-38.
10. Greenhalgh, D. & Lewis, F. (2000) Three-stage AIDS incubation period: a best case scenario using addictneedle interaction assumptions. IMA J. Math. Med. Biol., 17, 95-118.
11. Griesbach, D., Abdulrahim, D., Gordon, D. & Dowell, K. (2006) Needle exchange provision in Scotland: a report of the national needle exchange survey. Technical Report. UK: Scottish Executive.
12. Hagan, H. & Des Jarlais, D. (2000) HIV and HCV infection among injecting drug users. Mt. Sinai J. Med., 67, 423-428.
13. Health Protection Agency (2009) Hepatitis C in the UK 2009. Technical Report. UK: Health Protection Agency Centre for Infections.
14. HPS (1990-1993). Health Protection Scotland Survey Data. Glasgow, UK: Health Protection Scotland.
15. Hutchinson, S., Bird, S., Taylor, A. & Goldberg, D. (2006) Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: implications for prevention. Int. J. Drug Policy, 17, 211-221.
16. Hutchinson, S., Taylor, A., Goldberg, D. & Gruer, L. (2000) Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990 to 1994: implications for control and prevention of blood-borne viruses. Addiction, 95, 931-940.
17. Kaplan, E. H. (1989) Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Rev. Infect. Dis., 11, 289-298.
18. Kaplan, E. H. (1994) A method for evaluating needle exchange programmes. Stat. Med., 13, 2179-2187.
19. Kaplan, E. H. (1995) Probability models of needle exchange. Oper. Res., 43, 558-568.
20. Kaplan, E. H. & O'keefe, E. (1993) Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces, 23, 7-26.
21. King, R., Bird, S. M., Hay, G. & Hutchinson, S. J. (2009) Estimating current injectors in Scotland and their drug-related death rate by sex, region and age-group via Bayesian capture-recapture methods. Stat. Methods Med. Res., 18, 341-359.
22. Lewis, F. & Greenhalgh, D. (2001) Effects of variable infectivity on the spread of HIV/AIDS among intravenous drug users. J. Biol. Syst., 9, 13-40.
23. Macey, R., Oster, G. & Zahnley, T. (2000) Berkeley Madonna. Berkeley, CA: University of California. Available at www.berkeleymadonna.com.
24. May, R. M. (1974) Stability and Complexity of Model Ecosystems, 2nd edn. Princeton: Princeton University Press.
25. Mehta, S. H., Cox, A., Hoovere, D. R., Wang, X., Mao, Q., Ray, S., Strathdee, S. A., Vlahov, D. &Thomas, D. (2002) Protection against persistence of Hepatitis C. Lancet, 359, 1478-1483.
26. Micallef, J. M., Kaldor, J. M. & Dore, G. J. (2006) Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J. Viral Hepat., 13, 34-41.
27. Micallef, J. M., Macdonald, V., Jauncey, M., Amin, J., Rawlinson, W. & Van Beek. I. (2007) High incidence of hepatitis C virus infection within a cohort of injecting drug users. J. Viral Hepat., 14, 413-418.
28. Murray, J., Law, M., Gao, Z. & Kaldor, J. (2003) The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. Int. J. Epidemiol., 32, 708-714.
29. National Treatment Agency (2009) Does syringe cleaning work? Available at http://www.harmreduction works.org.uk/2films/doescleaningsyringeswork.html.
30. Nold, A. (1980) Heterogeneity in disease-transmission modelling. Math. Biosci., 52, 227-240.
31. Paintsil, E., He, H., Peters, C., Lindenbach, B. D. & Heimer, R. (2010) Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J. Infect. Dis., 202, 984-990.
32. Scottish Government. (2008) Hepatitis C action plan for Scotland, phase II. Available at http://www.scotland.gov.uk/Resource/Doc/222750/0059978.pdf.
33. Seitz, S. T. & Müller, G. E. (1994) Viral Load and Sexual Risk. Epidemiological and Policy Implications for HIV/AIDS. Modelling the AIDS Epidemic: Planning, Policy and Prediction. New York: Raven Press, pp. 461-480.
34. Thieme, H. R. (1993) Persistence under relaxed point-dissipativity (with application to an endemic model). SIAM J. Math. Anal., 24, 407-435.
35. Vickerman, P., Hickman, M. & Judd, A. (2007) Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study. Int. J. Epidemiol., 36, 396-405.
36. Vickerman, P., Platt, L. & Hawkes, S. (2009) Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sex. Transm. Infect., 85, 23-30.
37. World Health Organization. (2000) Hepatitis C Fact Sheet 164. Available at http://www.who.int/mediacentre/factsheets/fs164/en/.